These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27485003)

  • 41. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ji Luo Elucidates the CRISPR Gene Editing Technology, and How It May Affect Cancer Therapy in the Future.
    Luo J
    Oncology (Williston Park); 2016 Oct; 30(10):879. PubMed ID: 27753053
    [No Abstract]   [Full Text] [Related]  

  • 43. Cancer Screens: Better Together.
    Pruett-Miller SM
    CRISPR J; 2020 Feb; 3(1):12-14. PubMed ID: 32091251
    [No Abstract]   [Full Text] [Related]  

  • 44. The Anti-CRISPR Story: A Battle for Survival.
    Maxwell KL
    Mol Cell; 2017 Oct; 68(1):8-14. PubMed ID: 28985512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genome modification by CRISPR/Cas9.
    Ma Y; Zhang L; Huang X
    FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
    Kleinstiver BP; Pattanayak V; Prew MS; Tsai SQ; Nguyen NT; Zheng Z; Joung JK
    Nature; 2016 Jan; 529(7587):490-5. PubMed ID: 26735016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CRISPR-mediated targeting of HER2 inhibits cell proliferation through a dominant negative mutation.
    Wang H; Sun W
    Cancer Lett; 2017 Jan; 385():137-143. PubMed ID: 27815036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene Therapy.
    Gori JL; Hsu PD; Maeder ML; Shen S; Welstead GG; Bumcrot D
    Hum Gene Ther; 2015 Jul; 26(7):443-51. PubMed ID: 26068008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FISHing Out the Details of CRISPR Genome Tracks.
    Coté AJ; Raj A
    Biophys J; 2017 Mar; 112(6):1045-1046. PubMed ID: 28355532
    [No Abstract]   [Full Text] [Related]  

  • 51. CRISPR adaptation in Escherichia coli subtypeI-E system.
    Kiro R; Goren MG; Yosef I; Qimron U
    Biochem Soc Trans; 2013 Dec; 41(6):1412-5. PubMed ID: 24256229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bacterial CRISPR: accomplishments and prospects.
    Peters JM; Silvis MR; Zhao D; Hawkins JS; Gross CA; Qi LS
    Curr Opin Microbiol; 2015 Oct; 27():121-6. PubMed ID: 26363124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CRISPR Screens: The Right Tool for the Job.
    Russell A
    CRISPR J; 2019 Feb; 2():9-11. PubMed ID: 31021228
    [No Abstract]   [Full Text] [Related]  

  • 54. Flavivirus-Host Interaction Landscape Visualized through Genome-Wide CRISPR Screens.
    Kanojia A; Sharma M; Shiraz R; Tripathi S
    Viruses; 2022 Sep; 14(10):. PubMed ID: 36298718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of Essential Genes Using Sequential CRISPR and siRNA Screens.
    DeHart L; Yockey OP; Bakke J
    Methods Mol Biol; 2022; 2377():89-107. PubMed ID: 34709612
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CRISPR genetic screens to discover host-virus interactions.
    McDougall WM; Perreira JM; Reynolds EC; Brass AL
    Curr Opin Virol; 2018 Apr; 29():87-100. PubMed ID: 29684735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DrugThatGene: integrative analysis to streamline the identification of druggable genes, pathways and protein complexes from CRISPR screens.
    Canver MC; Bauer DE; Maeda T; Pinello L
    Bioinformatics; 2019 Jun; 35(11):1981-1984. PubMed ID: 30395160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SCEPTRE improves calibration and sensitivity in single-cell CRISPR screen analysis.
    Barry T; Wang X; Morris JA; Roeder K; Katsevich E
    Genome Biol; 2021 Dec; 22(1):344. PubMed ID: 34930414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells.
    Meyers RM; Bryan JG; McFarland JM; Weir BA; Sizemore AE; Xu H; Dharia NV; Montgomery PG; Cowley GS; Pantel S; Goodale A; Lee Y; Ali LD; Jiang G; Lubonja R; Harrington WF; Strickland M; Wu T; Hawes DC; Zhivich VA; Wyatt MR; Kalani Z; Chang JJ; Okamoto M; Stegmaier K; Golub TR; Boehm JS; Vazquez F; Root DE; Hahn WC; Tsherniak A
    Nat Genet; 2017 Dec; 49(12):1779-1784. PubMed ID: 29083409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CRISPR tiling screen reveals cancer epigenetic 'Goldilocks' state.
    Barka A; Kohli RM; Shi J
    Trends Pharmacol Sci; 2023 Sep; 44(9):555-557. PubMed ID: 37328396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.